Aarsland et al., 1999 D. Aarsland, JP. Larsen, NG. Lim, C. Janvin, K. Karlsen, E. Tandberg, JL. Cummings Range of neuropsychiatric disturbances in patients with Parkinson’s disease J. Neurol. Neurosurg. Psychiatry, 67 (1999), pp. 492–496 https://doi.org/10.1136/jnnp.67.4.492
Arnsten et al., 1995 AF. Arnsten, JX. Cai, JC. Steere, PS. Goldman-Rakic Dopamine D2 receptor mechanisms contribute to age-related cognitive decline: the effects of quinpirole on memory and motor performance in monkeys J. Neurosci., 15 (5 Pt 1) (1995), pp. 3429-3439
Barazzoni et al., 2000 R. Barazzoni, KR. Short, KS. Nair Effects of aging on mitochondrial DNA copy number and cytochrome c oxidase gene expression in rat skeletal muscle, liver, and heart J. Biol. Chem., 275 (5) (2000), pp. 3343-3347
Beniyama et al., 2013 Y. Beniyama, K. Matsuno, H. Miyachi Structure-guided design, synthesis and in vitro evaluation of a series of pyrazole-based fatty acid binding protein (FABP) 3 ligands
Bioorganic Med. Chem. Lett., 23 (2013), pp. 1662–1666 https://doi.org/10.1016/j.bmcl.2013.01.054
Bennett et al., 1994 E. Bennett, KL. Stenvers, PK. Lund, B. Popko Cloning and characterization of a cDNA encoding a novel fatty acid binding protein from rat brain J. Neurochem., 63 (5) (1994), pp. 1616-1624 https://doi.org/10.1046/j.1471-4159.1994.63051616.x
Bradford, 1976 MM. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem., 72 (1976), pp. 248-254
Broersen et al., 2006 K. Broersen, D. van den Brink, G. Fraser, M. Goedert, B.Davletov α-Synuclein adopts an α-helical conformation in the presence of polyunsaturated fatty acids to hinder micelle formation
Biochemistry, 45 (2006), pp. 15610–15616 https://doi.org/10.1021/bi061743l
Brichta et al., 2013 L. Brichta, P. Greengard, M. Flajolet Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems Trends. Neurosci., 36 (9) (2013), pp. 543-554
Cheng et al., 2019 A. Cheng, Y. Shinoda, T. Yamamoto, H. Miyachi, K. Fukunaga Development of FABP3 ligands that inhibit arachidonic acid-induced α-synuclein oligomerization Brain Res., 1707 (2019), pp. 190–197 https://doi.org/10.1016/j.brainres.2018.11.036
Chu, 2018 CT. Chu Multiple pathways for mitophagy: A neurodegenerative conundrum for Parkinson's disease Neurosci. Lett., S0304-3940 (18) 30259-3
Conley et al., 2000 KE. Conley, SA. Jubrias, PC. Esselman Oxidative capacity and ageing in human muscle J. Physiol., 526 Pt 1 (2000), pp. 203-210
Conway et al., 2001 KA. Conway, JC. Rochet, RM. Bieganski, PT. Jr. Lansbury Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct Science (80-. ), 294 (2001), pp. 1346–1349 https://doi.org/10.1126/science.1063522
Crane et al., 2010 JD. Crane, MC. Devries, A. Safdar, MJ. Hamadeh, MA. Tarnopolsky The effect of aging on human skeletal muscle mitochondrial and intramyocellular lipid ultrastructure J. Gerontol. A. Biol. Sci. Med. Sci., 65 (2) (2010), pp. 119-128
Crawford et al., 2011 RS. Crawford, H. Albadawi, MD. Atkins, JJ. Jones, MF. Conrad, WG Jr. Austen, MP. Fink, MT. Watkins Postischemic treatment with ethyl pyruvate prevents adenosine triphosphate depletion, ameliorates inflammation, and decreases thrombosis in a murine model of hind-limb ischemia and reperfusion J. Trauma., 70 (1) (2011), pp. 103-110
Csordás et al., 2006 G. Csordás, C. Renken, P. Várnai, L. Walter, D. Weaver, KF. Buttle, T. Balla, CA. Mannella, G. Hajnóczky Structural and functional features and significance of the physical linkage between ER and mitochondria J. Cell Biol., 174 (7) (2006), pp. 915-921
da Silva et al., 2012 WC. da Silva, CC. Köhler, A. Radiske, M. Cammarota D1/D5 dopamine receptors modulate spatial memory formation Neurobiol. Learn. Mem., 97 (2) (2012), pp. 271-275
Dang, 2010 CV. Dang Rethinking the Warburg effect with Myc micromanaging glutamine metabolism Cancer Res., 70 (3) (2010), pp. 859-862
Dauer and Przedborski, 2003 W. Dauer, S. Przedborski Parkinson's disease: mechanisms and models Neuron, 39 (6) (2003), pp. 889-909
Davé et al., 2009 SH. Davé, JS. Tilstra, K. Matsuoka, F. Li, RA. DeMarco, D. Beer-Stolz, AR. Sepulveda, MP. Fink, MT. Lotze, SE. Plevy Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis J. Leukoc. Biol., 86 (3) (2009), pp. 633-643
De Franceschi et al., 2009 G. De Franceschi, E. Frare, L. Bubacco, S. Mammi, A. Fontana, PP. de Laureto Molecular insights into the interaction between α-synuclein and docosahexaenoic acid J. Mol. Biol., 394 (2009), pp. 94–107 https://doi.org/10.1016/j.jmb.2009.09.008
de Lima et al., 2011 MN. de Lima, J. Presti-Torres, A. Dornelles, FS. Scalco, R. Roesler, VA. Garcia, N. Schröder Modulatory influence of dopamine receptors on consolidation of object recognition memory Neurobiol. Learn. Mem., 95 (3) (2011), pp. 305-310
Edgar and Trifunovic, 2009 D. Edgar, A. Trifunovic The mtDNA mutator mouse: Dissecting mitochondrial involvement in aging Aging (Albany NY), 1 (12) (2009), pp. 1028-1032
Eichenbaum et al., 1992 H. Eichenbaum, T. Otto, NJ. Cohen The hippocampus--what does it do? Behav. Neural. Biol., 57 (1) (1992), pp. 2-36
Fahn, 1999 S. Fahn Parkinson disease, the effect of levodopa, and the ELLDOPA trial Arch. Neurol., 56 (1999), pp. 529–535 https://doi.org/10.1001/archneur.56.5.529
Fahn et al., 2004 S. Fahn, D. Oakes, I. Shoulson, K. Kieburtz, A. Rudolph, A. Lang, CW. Olanow, C. Tanner, K. Marek; Parkinson Study Group Levodopa and the progression of Parkinson's disease N. Engl. J. Med., 351 (24) (2004), pp. 2498-2508 https://doi.org/10.1056/NEJMoa033447
Feng et al., 1994 L. Feng, ME. Hatten, N. Heintz Brain lipid-binding protein (BLBP): A novel signaling system in the developing mammalian CNS Neuron, 12 (1994), pp. 895–908 https://doi.org/10.1016/0896-6273(94)90341-7
Filippini et al., 1990 A. Filippini, RE. Taffs, T. Agui, MV. Sitkovsky Ecto-ATPase activity in cytolytic T-lymphocytes. Protection from the cytolytic effects of extracellular ATP J. Biol. Chem., 265 (1) (1990), pp. 334-340
Fujita et al., 2009 K. Fujita, T. Seike, N. Yutsudo, M. Ohno, H. Yamada, H. Yamaguchi, K. Sakumi, Y. Yamakawa, MA. Kido, A. Takaki, T. Katafuchi, Y. Tanaka, Y. Nakabeppu, M. Noda Hydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease PLoS One, 4 (9) (2009), p. e7247
Fukae et al., 2015 J. Fukae, MA. Higuchi, S. Yanamoto, K. Fukuhara, J. Tsugawa, S. Ouma, T. Hatano, A. Yoritaka, Y. Okuma, K. Kashihara, N. Hattori, Y. Tsuboi Utility of the Japanese version of the 9-item Wearing-off Questionnaire Clin. Neurol. Neurosurg., 134 (2015), pp. 110-115
Gasbarri et al., 1994 A. Gasbarri, C. Verney, R. Innocenzi, E. Campana, C. Pacitti Mesolimbic dopaminergic neurons innervating the hippocampal formation in the rat: a combined retrograde tracing and immunohistochemical study Brain Res., 668 (1994), pp. 71–79 https://doi.org/10.1016/0006-8993(94)90512-6
Giguere et al., 2018 N. Giguere, C. Pacelli, C. Saumure, MJ. Bourque, D. Matheoud,D. Levesque, RS. Slack, DS. Park, LE. Trudeau Comparative analysis of Parkinson's disease-associated genes reveals altered survival and bioenergetics of parkin-deficient dopamine neurons in mice J. Biol. Chem., 293 (25) (2018), pp. 9580-9593
Gordon, 1987 N. Gordon Peroxisomal disorders Brain Dev., 9 (1987), pp. 571–575 https://doi.org/10.1016/S0387-7604(87)80087-6
Gordon, 1997 N. Gordon Nutrition and cognitive function Brain Dev., 19 (1997), pp. 165–170 https://doi.org/10.1016/S0387-7604(96)00560-8
Granado et al., 2008 N. Granado, O. Ortiz, LM. Suárez, ED. Martín, V. Ceña, JM. Solís, R. Moratalla D1 but not D5 Dopamine Receptors Are Critical for LTP, Spatial Learning, and LTP-Induced arc and zif268 Expression in the Hippocampus Cereb. Cortex, 18 (1) (2008), pp. 1–12
Hamosh and Salem, 1998 M. Hamosh, N. Jr. Salem Long-chain polyunsaturated fatty acids Biol. Neonate., 74 (2) (1998), pp. 106-120 https://doi.org/10.1159/000014017
Hayashi and Su, 2007 T. Hayashi, TP. Su Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival Cell, 131 (3) (2007), pp. 596-610
Hersi et al., 1995 AI. Hersi, JW. Richard, P. Gaudreau, R. Quirion Local modulation of hippocampal acetylcholine release by dopamine D1 receptors: a combined receptor autoradiography and in vivo dialysis study J. Neurosci., 115 (11) (1995), pp. 7150-7157
Heuckeroth et al., 1987 RO. Heuckeroth, EH. Birkenmeier, MS. Levin, JI. Gordon Analysis of the tissue-specific expression, developmental regulation, and linkage relationships of a rodent gene encoding heart fatty acid binding protein J. Biol. Chem., 262 (1987), pp. 9709–9717
Hornykiewicz, 1966 O. Hornykiewicz Dopamine (3-hydroxytyramine) and brain function Pharmacol. Rev., 18 (2) (1966), pp. 925-964
Huh et al., 2011 SH. Huh, YC. Chung, Y. Piao, MY. Jin, HJ. Son, NS. Yoon, JY. Hong, YK. Pak, YS. Kim, JK. Hong, O. Hwang, BK. Jin Ethyl pyruvate rescues nigrostriatal dopaminergic neurons by regulating glial activation in a mouse model of Parkinson's disease J. Immunol., 187 (2) (2011), pp. 960-969
Kao and Fink, 2010 KK. Kao, MP. Fink The biochemical basis for the anti-inflammatory and cytoprotective actions of ethyl pyruvate and related compounds Biochem. Pharmacol., 80 (2) (2010), pp. 151-159
Kazantsev and Kolchinsky, 2008 AG. Kazantsev, AM. Kolchinsky Central role of α-synuclein oligomers in neurodegeneration in parkinson disease Arch. Neurol., 65 (2008), pp. 1577–1581 https://doi.org/10.1001/archneur.65.12.1577
Kemp and Foe, 1983 RG. Kemp, LG. Foe Allosteric regulatory properties of muscle phosphofructokinase Mol. Cell. Biochem., 57 (2) (1983), pp. 147-154
Kim et al., 2008 HS. Kim, IH. Cho, JE. Kim, YJ. Shin, JH. Jeon, Y. Kim, YM. Yang, KH. Lee, JW. Lee, WJ. Lee, SK. Ye, MH. Chung Ethyl pyruvate has an anti-inflammatory effect by inhibiting ROS-dependent STAT signaling in activated microglia Free Radic. Biol. Med., 45 (7) (2008), pp. 950-963
Kurtz et al., 1994 A. Kurtz, A. Zimmer, F. Schnütgen, G. Brüning, F. Spener, T. Müller The expression pattern of a novel gene encoding brain-fatty acid binding protein correlates with neuronal and glial cell development Development, 120 (1994), pp. 2637–2649.
Laemmli, 1970 UK. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature, 227 (5259) (1970), pp. 680-685
Lee et al., 2001 JY. Lee, YH. Kim, JY. Koh Protection by pyruvate against transient forebrain ischemia in rats J. Neurosci., 21 (20) (2001), p. RC171
Lemon and Manahan-Vaughan, 2006 N. Lemon, D. Manahan-Vaughan Dopamine D1/D5 receptors gate the acquisition of novel information through hippocampal long-term potentiation and long-term depression J. Neurosci., 26 (29) (2006), pp. 7723-7729
Luciana et al., 1998 M. Luciana, PF. Collins, RA. Depue Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions Cereb. Cortex, 8 (3) (1998), pp. 218-226
Manning-Bog et al., 2002 AB. Manning-Bog, AL. McCormack, J. Li, VN. Uversky, AL. Fink, DA. Di Monte The herbicide paraquat causes up-regulation and aggregation of α-synuclein in mice: Paraquat and α-synuclein J. Biol. Chem., 277 (2002), pp. 1641–1644 https://doi.org/10.1074/jbc.C100560200
Marsden and Parkes, 1976 CD. Marsden, JD. Parkes“On-off” effects in patients with Parkinson’s disease on chronic levodopa therapy Lancet, 307 (1976), pp. 292–296 https://doi.org/10.1016/S0140-6736(76)91416-1
Matsuo et al., 2019 K. Matsuo, A. Cheng, Y. Yabuki, I. Takahata, H. Miyachi, K. Fukunaga Inhibition of MPTP-induced α-synuclein oligomerization by fatty acid-binding protein 3 ligand in MPTP-treated mice Neuropharmacology, 150 (2019), pp. 164–174 https://doi.org/10.1016/j.neuropharm.2019.03.029
Mazzio and Soliman, 2003 E. Mazzio, KF. Soliman Pyruvic acid cytoprotection against 1-methyl-4-phenylpyridinium, 6-hydroxydopamine and hydrogen peroxide toxicities in vitro Neurosci. Lett., 337 (2) (2003), pp. 77-80
Mollenhauer et al., 2007 B. Mollenhauer, P. Steinacker, E. Bahn, M. Bibl, P. Brechlin, MG. Schlossmacher, JJ. Locascio, J. Wiltfang, HA. Kretzschmar, S. Poser, C. Trenkwalder, M. Otto Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: Marker candidates for dementia with Lewy bodies Neurodegener. Dis., 4 (2007), pp. 366–375 https://doi.org/10.1159/000105157
Montgomery and Webb, 1956 CM. Montgomery, JL. Webb Metabolic studies on heart mitochondria. II. The inhibitory action of parapyruvate on the tricarboxylic acid cycle J. Biol. Chem., 221 (1) (1956), pp. 359-368
Moriguchi et al., 2012 S. Moriguchi, Y. Yabuki, K. Fukunaga Reduced calcium/calmodulin-dependent protein kinase II activity in the hippocampus is associated with impaired cognitive function in MPTP-treated mice J. Neurochem., 120 (4) (2012), pp. 541-551
Moritz et al., 2015 C. Moritz, F. Berardi, C. Abate, F. Peri Live imaging reveals a new role for the sigma-1 (σ1) receptor in allowing microglia to leave brain injuries Neurosci. Lett., 591 (2015), pp. 13-18
Moro and Sutton, 2010 N. Moro, RL. Sutton Beneficial effects of sodium or ethyl pyruvate after traumatic brain injury in the rat Exp. Neurol., 225 (2) (2010), pp. 391-401
Muskiet and Kemperman, 2006 FAJ. Muskiet, RFJ. Kemperman Folate and long-chain polyunsaturated fatty acids in psychiatric disease J. Nutr. Biochem., 17 (2006), pp. 717–727 https://doi.org/10.1016/j.jnutbio.2006.02.001
Nakano et al., 2017 M. Nakano, H. Imamura, N. Sasaoka, M. Yamamoto, N. Uemura,T. Shudo, T. Fuchigami, R. Takahashi, A. Kakizuka ATP Maintenance via Two Types of ATP Regulators Mitigates Pathological Phenotypes in Mouse Models of Parkinson's Disease EBioMedicine, 22 (2017), pp. 225-241
Nakazawa et al., 1998 M. Nakazawa, K. Matsuno, S. Mita Activation of sigma1 receptor subtype leads to neuroprotection in the rat primary neuronal cultures Neurochem. Int., 32 (4) (1998), pp. 337-343
Neher et al., 2012 MD. Neher, S. Weckbach, MS. Huber-Lang, PF. Stahel New insights into the role of peroxisome proliferator-activated receptors in regulating the inflammatory response after tissue injury PPAR Res., (2012) https://doi.org/10.1155/2012/728461
Obeso et al., 2000 JA. Obeso, MC. Rodriguez-Oroz, P. Chana, G. Lera, M. Rodriguez, CW. Olanow The evolution and origin of motor complications in Parkinson's disease Neurology, 55 (11 Suppl 4) (2000), S13-20; discussion S21-3
Olanow and Tatton, 1999 CW. Olanow, WG. Tatton Etiology and pathogenesis of Parkinson's disease Annu. Rev. Neurosci., 22 (1999), pp. 123-144
Ordureau et al., 2018 A. Ordureau, JA. Paulo, W. Zhang, T. Ahfeldt, J. Zhang, EF. Cohn, Z. Hou, JM. Heo, LL. Rubin, SS. Sidhu, SP. Gygi, JW. Harper Dynamics of PARKIN-Dependent Mitochondrial Ubiquitylation in Induced Neurons and Model Systems Revealed by Digital Snapshot Proteomics Mol. Cell., 70 (2) (2018), pp. 211-227
Ortiz et al., 2010 O. Ortiz, JM. Delgado-García, I. Espadas, A. Bahí, R. Trullas, JL. Dreyer, A. Gruart, R. Moratalla Associative learning and CA3-CA1 synaptic plasticity are impaired in D1R null, Drd1a-/- mice and in hippocampal siRNA silenced Drd1a mice J. Neurosci., 30 (37) (2010), pp. 12288-12300
Pan et al., 2012 R. Pan, Z. Rong, Y. She, Y. Cao, LW. Chang, WH. Lee Sodium pyruvate reduces hypoxic-ischemic injury to neonatal rat brain Pediatr. Res., 72 (5) (2012), pp. 479-489
Paumier et al., 2015 KL. Paumier, KC. Luk, FP. Manfredsson, NM. Kanaan, JW. Lipton, TJ. Collier, K. Steece-Collier, CJ. Kemp, S. Celano, E. Schulz, IM. Sandoval, S. Fleming, E. Dirr, NK. Polinski, JQ. Trojanowski, VM. Lee, CE. Sortwell Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration Neurobiol. Dis., 82 (2015), pp. 185–199 https://doi.org/10.1016/j.nbd.2015.06.003
Paxinos and Franklin, 2001 G. Paxinos, K. Franklin The Mouse Brain in Stereotaxic Coordinates Academic, San Diego (2001)
Pickrell and Youle, 2015 AM. Pickrell, RJ. Youle The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease Neuron, 85 (2) (2015), pp. 257-273
Pillon et al., 1989 B. Pillon, B. Dubois, G. Cusimano, AM. Bonnet, F. Lhermitte, Y. Agid Does cognitive impairment in Parkinson’s disease result from non-dopaminergic lesions? J. Neurol. Neurosurg. Psychiatry, 52 (1989), pp. 201–206 https://doi.org/10.1136/jnnp.52.2.201
Pizzo et al., 1991 P. Pizzo, P. Zanovello, V. Bronte, F. Di Virgilio Extracellular ATP causes lysis of mouse thymocytes and activates a plasma membrane ion channel Biochem. J., 274 (Pt 1) (1991), pp. 139-144
Qin et al., 2007 Z. Qin, D. Hu, S. Han, SH. Reaney, DA. Di Monte, AL. Fink Effect of 4-hydroxy-2-nonenal modification on α-synuclein aggregation J. Biol. Chem., 282 (2007), pp. 5862–5870 https://doi.org/10.1074/jbc.M608126200
Ramos-Ibeas et al., 2017 P. Ramos-Ibeas, M. Barandalla, S. Colleoni, G. Lazzari Pyruvate antioxidant roles in human fibroblasts and embryonic stem cells Mol. Cell. Biochem., 429 (1-2) (2017), pp. 137-150
Regitz et al., 1981 V. Regitz, T. Azumi, H. Stephan, S. Naujocks, W. Schaper Biochemical mechanism of infarct size reduction by pyruvate Cardiovasc. Res., 15 (11) (1981), pp. 652-658
Reisch and Elpeleg, 2007 AS. Reisch, O. Elpeleg Biochemical assays for mitochondrial activity: assays of TCA cycle enzymes and PDHc Methods Cell Biol., 80 (2007), pp. 199-222
Ribarik Coe and Bernlohr, 1998 N. Ribarik Coe, DA. Bernlohr Physiological properties and functions of intracellular fatty acid- binding proteins Biochim. Biophys. Acta - Lipids Lipid Metab., 1391 (1998), pp. 287–306 https://doi.org/10.1016/S0005-2760(97)00205-1
Robb-Gaspers et al., 1998 LD. Robb-Gaspers, P. Burnett, GA. Rutter, RM. Denton, R.Rizzuto, AP. Thomas Integrating cytosolic calcium signals into mitochondrial metabolic responses EMBO J., 17 (17) (1998), pp. 4987-5000
Ruscher et al., 2011 K. Ruscher, M. Shamloo, M. Rickhag, I. Ladunga, L. Soriano, L. Gisselsson, H. Toresson, L. Ruslim-Litrus, D. Oksenberg, R. Urfer, BB. Johansson, K. Nikolich, T. Wieloch The sigma-1 receptor enhances brain plasticity and functional recovery after experimental strokeBrain, 134 (Pt 3) (2011), pp. 732-746
Sakul et al., 2013 A. Sakul, A. Cumaoğlu, E. Aydin, N. Ari, N. Dilsiz, C. Karasu Age- and diabetes-induced regulation of oxidative protein modification in rat brain and peripheral tissues: consequences of treatment with antioxidant pyridoindole Exp. Gerontol., 48 (2013), pp. 476-484
Satpute et al., 2013 R. Satpute, V. Lomash, M. Kaushal, R. Bhattacharya Neuroprotective effects of α-ketoglutarate and ethyl pyruvate against motor dysfunction and oxidative changes caused by repeated 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine exposure in mice Hum. Exp. Toxicol., 32 (7) (2013), pp. 747-758
Savitt et al., 2006 JM. Savitt, VL. Dawson, TM. Dawson Diagnosis and treatment of Parkinson disease: molecules to medicine J. Clin. Invest., 116 (7) (2006), pp. 1744-1754
Schapira, 1993 AH. Schapira Mitochondrial complex I deficiency in Parkinson's disease Adv. Neurol., 60 (1993), pp. 288-291
Shamir et al., 2017 R. Shamir, C. Klein, D. Amar, EJ. Vollstedt, M. Bonin, M. Usenovic, YC. Wong, A. Maver, S. Poths, H. Safer, JC. Corvol, S. Lesage, O. Lavi, G. Deuschl, G. Kuhlenbaeumer, H. Pawlack, I. Ulitsky, M. Kasten, O. Riess, A. Brice, B. Peterlin, D. Krainc Analysis of blood-based gene expression in idiopathic Parkinson disease Neurology, 89 (16) (2017), pp. 1676-1683
Sharon et al., 2001 R. Sharon, MS. Goldberg, I. Bar-Josef, RA. Betensky, J. Shen, DJ.Selkoe α-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins Proc. Natl. Acad. Sci. U. S. A., 98 (2001), pp. 9110–9115 https://doi.org/10.1073/pnas.171300598
Sharon et al., 2003 R. Sharon, I. Bar-Joseph, MP. Frosch, DM. Walsh, JA. Hamilton, DJ. Selkoe The formation of highly soluble oligomers of α-synuclein is regulated by fatty acids and enhanced in Parkinson’s disease Neuron, 37 (2003), pp. 583–595 https://doi.org/10.1016/S0896-6273(03)00024-2
Shen et al., 2010 H. Shen, X. Hu, C. Liu, S. Wang, W. Zhang, H. Gao, RA. Stetler, Y. Gao, J. Chen Ethyl pyruvate protects against hypoxic-ischemic brain injury via anti-cell death and anti-inflammatory mechanisms Neurobiol. Dis., 37 (3) (2010), pp. 711-722
Shin et al., 2014 JH. Shin, HK. Lee, HB. Lee, Y. Jin, JK. Lee Ethyl pyruvate inhibits HMGB1 phosphorylation and secretion in activated microglia and in the postischemic brain Neurosci. Lett., 558 (2014), pp. 159-163
Shioda et al., 2014 N. Shioda, Y. Yabuki, Y. Kobayashi, M. Onozato, Y. Owada, K. Fukunaga FABP3 protein promotes α-synuclein oligomerization associated with 1-Methyl-1,2,3,6-tetrahydropiridine-induced neurotoxicity J. Biol. Chem., 289 (2014), pp. 18957–18965 https://doi.org/10.1074/jbc.M113.527341
Short et al., 2005 KR. Short, ML. Bigelow, J. Kahl, R. Singh, J. Coenen-Schimke, S. Raghavakaimal, KS. Nair Decline in skeletal muscle mitochondrial function with aging in humans Proc. Natl. Acad. Sci. U. S. A., 102 (15) (2005), pp. 5618-5623
Shults et al., 1997 CW. Shults, RH. Haas, D. Passov, MF. Beal Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects Ann. Neurol., 42 (2) (1997), pp. 261-264
Simuni et al., 2015 T. Simuni, K. Kieburtz, B. Tilley, J. J Elm, B. Ravina, D. Babcock,M. Emborg, R. Hauser, C. Kamp, JC. Morgan, G. Webster Ross, D. K Simon, J. Bainbridge, L. Baker, I. Bodis-Wollner, J. Boyd, F. Cambi, J. Carter, K. Chou, CW. Christine, N. Dahodwala, RB. Dewey Jr., R. Dhall, J. Fang, B. Farrow, A. Feigin, S. Glazman, J. Goudreau, P. LeBlanc, S. Lee, M. Leehey, MF. Lew, S. Lowenhaupt, S. Luo, R. Pahwa, A. Perez, J. Schneider, B. Scott, B. Shah, KM. Shannon, S. Sharma, C. Singer, D. Truong, R. Wagner, K. Williams, A. Marie Wills, P. Shieen Wong, C. Zadikoff, R. Zweig
Pioglitazone in early Parkinson’s disease: A phase 2, multicentre, double-blind, randomised trial Lancet Neurol., 14 (2015), pp. 795–803 https://doi.org/10.1016/S1474-4422(15)00144-1
Stanisavljević et al., 2015 S. Stanisavljević, B. Jevtić, N. Djedović, D. Miljković Short term exposure to ethyl pyruvate has long term anti-inflammatory effects on microglial cells Biomed. Pharmacother., 72 (2015), pp. 11-16
Stocchi et al., 2013 F. Stocchi, A. Antonini, P. Barone, M. Tinazzi, M. Zappia, M. Onofrj, S. Ruggieri, L. Morgante, U. Bonuccelli, L. Lopiano, P. Pramstaller, A. Albanese, M. Attar, V. Posocco, D. Colombo, G. Abbruzzese Early DEtection of wEaring off in Parkinson disease: the DEEP study Parkinsonism Relat. Disord., 20 (2) (2013), pp. 204-211
Tagashira et al., 2013 H. Tagashira, C. Zhang, YM. Lu, H. Hasegawa, H. Kanai, F. Han, K. Fukunaga Stimulation of σ1-receptor restores abnormal mitochondrial Ca²⁺ mobilization and ATP production following cardiac hypertrophy Biochim. Biophys. Acta., 1830 (4) (2013), pp. 3082-3094
Tagashira et al., 2014 H. Tagashira, Y. Shinoda, N. Shioda, K. Fukunaga Methyl pyruvate rescues mitochondrial damage caused by SIGMAR1 mutation related to amyotrophic lateral sclerosis Biochim. Biophys. Acta., 1840 (12) (2014), pp. 3320-3334
Tan et al., 2002 NS. Tan, NS. Shaw, N. Vinckenbosch, P. Liu, R. Yasmin, B. Desvergne, W. Wahli, N. Noy Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription Mol. Cell. Biol., 22 (2002), pp. 6318–6318 https://doi.org/10.1128/mcb.22.17.6318.2002
Tanaka et al., 2007 M. Tanaka, Y. Nishigaki, N. Fuku, T. Ibi, K. Sahashi, Y. Koga Therapeutic potential of pyruvate therapy for mitochondrial diseases Mitochondrion, 7 (2007), pp. 399-401
Tanila et al., 1998 H. Tanila, M. Björklund, P. Riekkinen Jr. Cognitive changes in mice following moderate MPTP exposure Brain Res. Bull., 45 (1998), pp. 577–582 https://doi.org/10.1016/s0361-9230(97)00452-8
Ulloa et al., 2002 L. Ulloa, M. Ochani, H. Yang, M. Tanovic, D. Halperin, R. Yang, CJ. Czura, MP. Fink, KJ. Tracey Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation Proc. Natl. Acad. Sci. U. S. A., 99 (19) (2002), pp. 12351-12356
Vander Heiden et al., 2009 MG. Vander Heiden, LC. Cantley, CB. Thompson Understanding the Warburg effect: the metabolic requirements of cell proliferation Science, 324 (5930) (2009), pp. 1029-1033
Vonkorff, 1964 RW. Vonkorff PYRUVATE-C14, PURITY AND STABILITY Anal. Biochem., 8 (1964), pp. 171-178
Walsh and Bennett, 2001 K. Walsh, G. Bennett Parkinson’s disease and anxiety Postgrad. Med. J., 77 (2001), pp. 89–93 https://doi.org/10.1136/pmj.77.904.89
Webb et al., 2015 BA. Webb, F. Forouhar, FE. Szu, J. Seetharaman, L. Tong, DL. Barber Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations Nature, 523 (7558) (2015), pp. 111-114
Whone et al., 2003 AL. Whone, RL. Watts, AJ. Stoessl, M. Davis, S. Reske, C. Nahmias, AE. Lang, O. Rascol, MJ. Ribeiro, P. Remy, WH. Poewe, RA. Hauser, DJ. Brooks; REAL-PET Study Group Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study Ann. Neurol., 54 (1) (2003), pp. 93-101 https://doi.org/10.1002/ana.10609
Woo et al., 2004 YJ. Woo, MD. Taylor, JE. Cohen, V. Jayasankar, LT. Bish, J. Burdick, TJ. Pirolli, MF. Berry, V. Hsu, T. Grand Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia J. Thorac. Cardiovasc. Surg., 127 (5) (2004), pp. 1262-1269
Yabuki and Fukunaga, 2013 Y. Yabuki, K. Fukunaga Oral administration of glutathione improves memory deficits following transient brain ischemia by reducing brain oxidative stress Neuroscience, 250 (2013), pp. 394-407
Yabuki et al., 2014 Y. Yabuki, Y. Ohizumi, A. Yokosuka, Y. Mimaki, K. Fukunaga Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model miceNeuroscience, 259 (2014), pp. 126-141
Yabuki et al., 2015 Y. Yabuki, Y. Shinoda, H. Izumi, T. Ikuno, N. Shioda, K. Fukunaga Dehydroepiandrosterone administration improves memory deficits following transient brain ischemia through sigma-1 receptor stimulationBrain Res., 1622 (2015), pp. 102-113
Zanovello et al., 1990 P. Zanovello, V. Bronte, A. Rosato, P. Pizzo, F. Di Virgilio Responses of mouse lymphocytes to extracellular ATP. II. Extracellular ATP causes cell type-dependent lysis and DNA fragmentationJ. Immunol., 145 (5) (1990), pp. 1545-1550
Zarrindast et al., 2012 MR. Zarrindast, A. Ardjmand, S. Ahmadi, A. Rezayof Activation of dopamine D1 receptors in the medial septum improves scopolamine-induced amnesia in the dorsal hippocampus Behav. Brain Res., 229 (1) (2012), pp. 68-73
Zeng et al., 2007 J. Zeng, J. Liu, GY. Yang, MJ. Kelly, TL. James, L. Litt Exogenous ethyl pyruvate versus pyruvate during metabolic recovery after oxidative stress in neonatal rat cerebrocortical slices Anesthesiology, 107 (4) (2007), pp. 630-640
Zhong et al., 2013 Z. Zhong, T. Zeng, K. Xie, C. Zhang, J. Chen, Y. Bi, X. Zhao Elevation of 4-hydroxynonenal and malondialdehyde modified protein levels in cerebral cortex with cognitive dysfunction in rats exposed to 1-bromopropane Toxicology, 306 (2013), pp. 16-23
Zhou et al., 2013 L. Zhou, J. Jin, G. Song, H. Liu, M. Liu, C. Shi, L. Qianα-Lipoic acid ameliorates mitochondrial impairment and reverses apoptosis in FABP3-overexpressing embryonic cancer cells J. Bioenerg. Biomembr., 45 (2013), pp. 459–466 https://doi.org/10.1007/s10863-013-9506-z
論文の公開元へ
